Molecular Endocrinology · 1993 · 36 citations · 14 references
Life SciencesBiochemistryMolecular BiologyGene ExpressionGene RegulationSignal TransductionAdrenal Axis RegulationAdrenal HormonesAdrenal SteroidogenesisHormone Gene RegulationHormone Signal TransductionProtein SynthesisAdrenal Hormone BiochemistryAdrenal Transcriptional RegulationAp-1 Transcriptional ControlCyclic Adenosine Monophosphate PathwayCyclic Adenosine Monophosphate SignalingFos OncogenesIndirect Immunofluorescence AssayProtein Expression Levels
We report the results of an extensive kinetic analysis of the effects of ACTH, cAMP derivatives (dibutyryl cAMP and 8-bromo-cAMP) and phorbol ester (phorbol-12-myristate-13-acetate) on the expression of fos and jun gene family members at the mRNA (Northern hybridization) and protein levels (immunoprecipitation and indirect immunofluorescence) in the mouse Y-1 adrenocortical cell line. FOS and JUN proteins are induced by ACTH independently of cell cycle stage. c-Fos, fos-B, fra-1, fra-2, c-jun, and jun-B genes are induced by ACTH, the kinetic profiles for mRNAs and respective protein products being similar, except for a 1-h protein delay. Jun-D mRNA is an exception, being constitutively expressed. However, JUN D protein is induced by ACTH. phorbol-12-myristate-13-acetate closely mimics these inductive effects of ACTH. On the other hand, cAMP derivatives are not effective in inducing the fos and jun genes, except for fra-2 mRNA, JUN D protein, and to some extent JUN B protein. Clearly, ACTH is endowed with the versatile capability of modulating fos and jun gene expression, suggesting that AP-1 transcription factors play a role in ACTH mechanisms of action. ACTH receptors are likely to activate signaling routes other than the classical cAMP/protein kinase A in order to induce FOS and JUN proteins.
14
Characterization of junD: a new member of the jun proto‐oncogene family.
Syu-ichi Hirai, Rolf-Peter Ryseck, R Bravo et al. · The EMBO Journal · 1989 · 482 citations · Full text